---
title: Differentiation of BCMA-specific induced pluripotent stem cells into CD8ab+
  T cells targeting myeloma
date: '2023-10-27'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37890146/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20231028180731&v=2.17.9.post6+86293ac
source: Blood
description: 'A major hurdle in adoptive T cell therapy is cell exhaustion and failure
  to maintain anti-tumor responses. Here, we introduce an induced pluripotent stem
  cell (iPSC) strategy for reprogramming and revitalization of precursor exhausted
  BCMA-specific T cells to effectively target multiple myeloma (MM). Heteroclitic
  BCMA72-80 LMFLLRKI)-specific CD8+ memory cytotoxic T lymphocytes (CTL) were epigenetically
  reprogrammed to a pluripotent state, developed into hematopoietic progenitor cells
  (HPC: ...'
disable_comments: true
---
A major hurdle in adoptive T cell therapy is cell exhaustion and failure to maintain anti-tumor responses. Here, we introduce an induced pluripotent stem cell (iPSC) strategy for reprogramming and revitalization of precursor exhausted BCMA-specific T cells to effectively target multiple myeloma (MM). Heteroclitic BCMA72-80 LMFLLRKI)-specific CD8+ memory cytotoxic T lymphocytes (CTL) were epigenetically reprogrammed to a pluripotent state, developed into hematopoietic progenitor cells (HPC: ...